On May 11, Barclays raised its price recommendation on Becton, Dickinson and Company (NYSE:BDX) to $204 from $202. It reiterated an Overweight rating on the shares following the company’s fiscal Q2 ...

Urinary incontinence (UI) imposes a substantial clinical and economic burden. The PureWick™ device is a non-invasive alternative for women to pads/diapers and indwelling catheters, but its value has ...

FRANKLIN LAKES, N.J. , April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new clinical findings revealing that ...

New study findings published in the Journal of Clinical Medicine highlight the ease of use and comfort of BD PureWick® Female External Catheter can support a better night's rest FRANKLIN LAKES, N.J. , ...

Medicare covers PureWick®, yet many patients still pay out of pocket due to plan differences, documentation gaps, and a limited number of approved suppliers. We’ve filed tens of thousands of claims ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript August 7, 2025 Becton, Dickinson and Company beats earnings expectations. Reported EPS is $3.68, expectations were $3.4.

Urinary wicking devices are designed to help manage incontinence. A recent innovation in this area is the PureWick system, which is intended for use among females while they're asleep or resting. This ...

Reno, Nevada (UroToday.com) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, introduces the PureWick™ Portable Collection System, a discreet, ...

Becton, Dickinson and Company BDX, popularly known as BD, expanded its PureWick portfolio with a new first-of-its-kind Portable Collection System designed to help wheelchair users manage urinary ...